TL;DR Flo Health, the world’s largest women’s health app with 80 million monthly active users, is launching a new suite of perimenopause tools for premium subscribers in May 2026. A Wakefield Research survey found 66% of US women aged 38-50 felt better prepared for puberty than perimenopause. The tools include a Symptom Checker, Perimenopause Score, […]
Read MoreTag: health tech
Corti opens its clinical-AI stack to startups as Europe’s regulatory bill rises
The Copenhagen company says its Symphony model has outscored OpenAI on HealthBench Professional, and is offering credits and regulatory help to founders building healthcare AI worldwide. Corti, the Copenhagen-based clinical AI company, has launched a no-equity accelerator for healthcare and life sciences startups, opening its Symphony model stack to founders worldwide at a moment when […]
Read MoreBMS just signed a $15.2 billion drug deal with China’s biggest pharma company. The patent cliff left it no choice.
TL;DR Bristol Myers Squibb signed a $15.2 billion deal with China’s Hengrui Medicine for 13 early-stage drug programmes, as Big Pharma’s patent cliff makes Chinese innovation the fastest path to commercial survival — even as the BIOSECURE Act tries to decouple the two countries’ biotech sectors. Bristol Myers Squibb has signed a deal worth up […]
Read MoreDuch Ditto raises €7.6M for patient-side AI summaries of medical appointments
Ditto, an Amsterdam-based health-tech building AI-generated summaries of medical appointments for patients, has raised €7.6m, the company said on Monday. The round is led by Heal Capital with participation from Rubio Impact Ventures. Earlier backer Chris Oomen, chair of Optiverder, has also participated. The funding will support expansion into Germany, the UK, and Spain this […]
Read MoreNovo Nordisk hands shelved Parkinson’s cell therapy to Zuckerberg-backed Cellular Intelligence
Novo will take an equity stake in Cellular Intelligence and is in line for future milestone payments and royalties. The startup plans to apply its AI platform to STEM-PD, a stem-cell-derived treatment Novo discontinued last October. Novo Nordisk has handed over STEM-PD, an experimental stem-cell therapy for Parkinson’s disease, to Cellular Intelligence, an AI biotech […]
Read More
mbiomics raises €30M Series A to take its microbiome cancer co-therapy into clinical trials
The Munich techbio company is developing a live bacterial product designed to enhance immune checkpoint inhibitor response in advanced melanoma, with a Phase 1B study planned for 2027 mbiomics GmbH, a Munich-based techbio company developing microbiome-based therapeutics, has completed the third and final closing of its Series A funding round, bringing the total raised to […]
Read More
What’s the Best Medical Alert System of 2026? Comparing 7 major brands
Medical alert systems have become an essential safety tool for older adults who want to maintain their independence while ensuring help is available at the press of a button. These devices connect users to trained emergency operators 24/7, providing peace of mind for both seniors and their families. In recent years, the medical alert industry […]
Read MoreCoral raises $12.5M to automate healthcare’s administrative back office
The New York startup has built AI that reads handwritten fax forms, processes prior authorisations, and completes patient intakes in under five minutes, all without asking providers to change how they work. It has reached multiple millions in revenue in under a year and is targeting 4x growth by end of 2026. Coral, the New […]
Read MoreONWARD Medical raises €40.6M to advance its spinal cord stimulation implant
The Eindhoven neurotechnology company is using the proceeds to fund its Empower BP pivotal trial, which tests whether its implantable ARC-IM® system can treat blood pressure instability after spinal cord injury, while expanding commercial rollout of its already-cleared ARC-EX® external therapy system. Cash runway now extends to Q1 2028. ONWARD Medical has raised €40.6 million […]
Read More
Stockholm’s BioLamina secures €20M EIB loan to scale the protein matrices that make cell therapies possible
The European Investment Bank is lending €20 million to BioLamina, the Swedish biotech that supplies the laminin-based cell culture matrices used by stem cell therapy developers worldwide. The funding will support expanded production of laminin technologies and animal-free drug safety testing methods. BioLamina, the Stockholm-based biotechnology company that produces the protein scaffolding used to grow […]
Read MoreCambridge biotech STORM Therapeutics raises $56M
STC-15 is the world’s first RNA-modifying enzyme inhibitor to reach human trials. Phase 1 showed durable tumour regression across multiple sarcoma subtypes. The $56M Series C is backed entirely by existing investors including Pfizer Ventures and M Ventures. STORM Therapeutics, a Cambridge-based clinical-stage biotech targeting RNA modifications to treat cancer, has raised $56 million in […]
Read More
Amazon launches AI Bio platform to accelerate early-stage drug discovery
Amazon Web Services (AWS) announced this Tuesday the launch of its AI bio tool, Amazon Bio Discovery, to accelerate the early-stage process of drug discovery in the pharmaceutical industry. The application aims to help scientists design and test novel drugs in a fast and secure way. Amazon Bio Discovery enables scientists to run complex computational […]
Read More
Science Corp is preparing to place its first brain sensor in a human, betting biology will beat electrodes
Science Corporation, the BCI company founded by ex-Neuralink president Max Hodak, is preparing to place a pea-sized, 520-electrode sensor on a human brain’s surface during already-scheduled surgery. Yale neurosurgery chair Murat Günel will lead the programme; trials could begin in 2027. The company also has PRIMA, a retinal implant that restored vision in 38 patients […]
Read More
Helical closes $10M seed to turn bio foundation models into systems
The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by redalpine, with the CEOs of Cohere and HuggingFace among the angel investors. Helical, a London-based pharma AI startup founded by three Luxembourgish childhood friends, has raised $10 million in […]
Read MoreAI can screen 15 million molecules in a day. It still can’t cure Alzheimer’s.
The drug discovery revolution is real but radically overstated, the health chatbots are a documented hazard, and the diseases that matter most remain stubbornly unsolved. At Novartis, sometime in late 2025, a team of researchers working on Huntington’s disease used generative AI to computationally design 15 million potential compounds for a type of molecule called […]
Read More
Utah let AI prescribe medicine
The case for AI prescription renewals is real. So is the case against trusting a state sandbox to catch the risks. In January, a security research firm called Mindgard sat down with a chatbot. The chatbot had been built by Doctronic, a health technology startup that had just become the first company in American history […]
Read More
HexemBio raises $10.4M for a stem cell rejuvenation therapy
The Berkeley biotech is backing a Nature-published approach that recreates the embryonic environment where blood stem cells first form, rather than reprogramming aged cells chemically or genetically. Its lead programme targets bone marrow transplant in blood cancers and has received FDA Orphan Drug Designation. HexemBio has publicly launched with a $10.4 million seed round led […]
Read MoreneuroClues closes €10M Series A to bring its eye-tracking Parkinson’s diagnostic to European and US neurologists
The French-Belgian medtech uses a portable headset to capture up to 800 infrared images per eye per second, extracting oculomotor biomarkers that can indicate Parkinson’s, Alzheimer’s, and multiple sclerosis years before clinical symptoms appear. It received CE certification in January 2025 and is targeting FDA clearance in 2026. neuroClues, a French-Belgian medtech company developing an […]
Read MoreAnthropic just paid $400 million for a startup with fewer than 10 people
Anthropic has acquired Coefficient Bio, a stealth biotech AI startup founded barely eight months ago, in an all-stock deal worth just over $400 million. The acquisition brings a team of fewer than 10 people, nearly all former Genentech computational biology researchers, into Anthropic’s healthcare and life sciences division, and it signals something larger than a […]
Read MoreGenerare raises €20M to decode the 97% of microbial chemistry
The Paris techbio company screens microbial genomes to find molecules that evolution spent three billion years producing, and claims to have characterised more novel small molecules in 2025 than the rest of the field combined. Alven and Daphni co-led the Series A. Generare, the Paris-based techbio company reading microbial genomes for molecules that drug development […]
Read More
Corti’s new Symphony AI beats OpenAI and Anthropic on medical coding
The Copenhagen-based health AI company built Symphony on peer-reviewed research from the largest medical coding study of its kind, treating coding as a reasoning task rather than a labelling problem. It’s available via API now. Medical coding, the process of converting clinical notes, diagnoses, and procedures into standardised alphanumeric codes used for billing, reporting, and […]
Read More
Finnish neurowellness startup Audicin raises $1.9M
The all-female-founded company, backed by Oura Health co-founders and Business Finland, uses brainwave entrainment to support focus, sleep, and recovery via background audio. Its new Sleep Headband targets secure environments where phones are banned. Audicin, the Finnish neurotechnology company using brainwave entrainment and auditory engineering to support nervous system regulation, has raised $1.9 million in […]
Read MoremyStoria raises $1.625M to support patients navigating complex reproductive health
The Ontario startup combines AI with trained human professionals to help patients navigate PCOS, endometriosis, fertility, and perimenopause, the conditions with the longest diagnostic delays and most fragmented care in the system. Graphite Ventures led the round. When a patient receives a specialist referral, a confusing test result, or a diagnosis that landed in their […]
Read MoreLaigo Bio closes €17M seed to advance SureTACs
The Dutch biotech’s SureTACs platform targets membrane proteins that have long eluded conventional drug discovery by engineering them out of existence rather than blocking them. Biovance Capital joins as new co-lead alongside Kurma Partners in a final close that brings the oversubscribed seed round to €17 million. Most drugs work by blocking proteins. They attach […]
Read MoreBlossom Health raises $20 million to put AI copilots alongside psychiatrists
Blossom Health, a New York-based telepsychiatry startup founded in 2024, has raised $20 million in combined seed and Series A funding to scale an AI-powered platform that pairs psychiatrists with clinical copilots and automated administrative support. The round was led by Headline, whose co-founder and managing partner Mathias Schilling is joining the company’s board. Village […]
Read MoreA new app wants to cure loneliness by getting people off their phones and into the same room
A startup called Friending has launched a social platform built around a premise that sounds almost quaint in 2026: helping people make friends by meeting in person. The app, based in Raleigh, North Carolina, connects users by shared interests and geographic proximity, then deliberately limits chat functionality to push them toward face-to-face meetings rather than […]
Read More
JAAQ raises $17M to embed clinically governed mental health content inside the digital tools people already use
The London-based platform, which already covers 1.5 million eligible lives across enterprise and healthcare deployments, is using the Series A to accelerate US market entry and deepen its clinical infrastructure, with a new CEO who sold his last company to Adobe. JAAQ, the London-based digital health engagement platform, has raised $17 million in a Series […]
Read MorePerplexity has launched Perplexity Health
The AI search company launches a suite of health data connectors, linking Apple Health, wearables, and electronic health records, making it the second major AI platform to integrate with Apple Health after OpenAI. Consumer health AI has become the year’s fastest-moving product category, and on Thursday Perplexity entered the race properly. The company launched Perplexity […]
Read MoreParallel raises €20M to deploy AI agents for hospital administrative work across Europe
Every patient discharge in a European hospital triggers a paperwork cascade. Clinical information from the stay must be converted into standardised codes, the ICD classifications and procedure codes that determine what a hospital gets paid. Someone has to navigate the legacy software, pull the right records, select the right codes, and enter them correctly. In […]
Read More
German biotech Kupando raises €10M more to take its innate immunity drug into the clinic
An extension to the company’s Series A brings total funding to €23 million and clears the path for the first human trial of KUP101, a dual TLR agonist targeting solid tumours and drug-resistant infections. Most immunotherapy research in oncology has concentrated on the adaptive immune system, the learned, antibody-generating machinery that checkpoint inhibitors like pembrolizumab […]
Read More
Oxford Medical Simulation secures £5M growth financing
The London-based healthtech company, which lets clinicians practise emergencies and difficult conversations in virtual reality, will use the capital to deepen its US footprint and accelerate AI-driven product development. Oxford Medical Simulation has raised £5 million in growth financing from Salica Investments, the London-based investment firm formerly known as Hambro Perks. The funding will support […]
Read More